FTC Requires Global Suppliers of Animal Health Products Elanco Animal Health, Inc. and Bayer Animal Health GmbH to Divest Assets in Three Product Markets, as a Condition of Merger

The Federal Trade Commission will require global suppliers of animal products, Elanco Animal Health, Inc. and Bayer Animal Health GmbH, to divest three animal health products to settle charges that Elancos proposed $7.6 billion acquisition of Bayerwould likely be anticompetitive in those markets.

Metadata
Provider: 
FTCFTC
URL: 
https://www.ftc.gov/news-events/press-releases/2020/07/ftc-requires-global-suppliers-animal-health-products-elancohttps://www.ftc.gov/news-events/press-releases/2020/07/ftc-requires-global-suppliers-animal-health-products-elanco
Retrieved on: 
Wednesday, July 15, 2020
Information
Tags: 
Economy, Articles, Companies, Aspirin, Bayer, IG Farben, Leverkusen, Eli Lilly and Company, Divestment
Summary
Key Points: 
  • The Federal Trade Commission will require global suppliers of animal products, Elanco Animal Health, Inc. and Bayer Animal Health GmbH, to divest three animal health products to settle charges that Elancos proposed $7.6 billion acquisition of Bayerwould likely be anticompetitive in those markets.
  • The Commission will appoint an interim monitor to oversee the divestitures.
  • When the Commission issues a consent order on a final basis, it carries the force of law with respect to future actions.
  • Each violation of such an order may result in a civil penalty of up to $43,280.
Copyright: 
2020 FTC. All Rights Reserved.